SMALL MOLECULES FOR IMMUNOGENIC TREATMENT OF CANCER
申请人:Capten Therapeutics Inc.
公开号:US20190062272A1
公开(公告)日:2019-02-28
The present invention relates to new compounds for immunogenic treatment of cancer. The compounds can be administered as a single agent or in combination with an anticancer drug including modulators of other immune pathways, especially immune checkpoint inhibitors that target CTLA-4, PD-1, and PD-L1 proteins. The compounds can produce neoantigens through irreversible protein binding in cancer cells and generate immune response.
Supercritical CO<sub>2</sub>-assisted synthesis of an ultrasensitive amphibious quantum dot-molecularly imprinted sensor
作者:A. Lourenço、R. Viveiros、A. Mouro、J. C. Lima、V. D. B. Bonifácio、T. Casimiro
DOI:10.1039/c4ra10179k
日期:——
A green supercritical CO2-assisted molecular imprinting protocol enabled the production of smart sensory particles, incorporating quantum dots, with molecular recognition to bisphenol A at very low concentrations (4 nM).